FDA Inspection 1284932 — New York Blood Center Inc
The FDA completed an inspection of New York Blood Center Inc on Sep 16, 2025 in St. Paul, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 16, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- St. Paul, MN (United States)